Noteworthy

Mar 20, 2017
While it is foundational to commercial operations, most European life sciences companies are not getting what they need from their customer data, writes Guillaume Roussel.
Mar 17, 2017
It is hard to resist the sensation that the rhetoric of Shakespeare's Henry V is informing much of the Brexit thinking in Westminster, writes Reflector.
Mar 17, 2017
Jeff R. Livingstone outlines the critical steps necessary to ensure an agile, responsive and streamlined supply chain.
Mar 17, 2017
Pharmaceutical Executive
With big data one of the hot healthcare topics of the moment, we gauge pharma’s response to the hype to see if the industry is poised to take advantage of the promise of advanced analytics.
Mar 14, 2017
Pharmaceutical Executive
Amid the push for a more intelligent and predictive supply chain, is it imperative for pharma companies to advance with their supply chain digitization strategies now—or is there still time to “wait and see?”
Mar 09, 2017
Meg Alexander sounds a warning that providers of rare medicines may be the next to land in the hot seat.
Mar 06, 2017
Pharmaceutical Executive
Attack on treaties and imports threatens international operations.
Mar 06, 2017
The European Commission's latest economic assessment of EU member states does not make for comfortable reading, writes Reflector.
Mar 03, 2017
Pharm Exec speaks to Chris Molloy, CEO of the newly established Medicines Discovery Catapult, which aims to establish new approaches to grow and sustain the UK's reputation for innovative, fast-to-patient drug discovery.
Mar 02, 2017
Geoff Newman looks at how pharma and biotech interim management has evolved in the last 20 years.
native1_300x100
lorem ipsum